The vaccination of people with co-morbidities has been rolled out in Baguio City last week following the vaccination of frontline healthcare workers who compose the priority A1 group.
The vaccination, which was rolled out at the University of the Baguio on March 31, was for people with co-morbidities aged 18 to 59 years or those who compose the A3 group.
The City Health Services Office reported that senior citizens, or those 60 years and above with co-morbidities, will have a separate vaccination schedule.
Under the city’s vaccination program, senior citizens are the next priority sector or A2 group, but they are not eligible for the Sinovac vaccines, which were administered to the first priority groups.
City Public Information Officer Aileen Refuerzo said the vaccination of senior citizens with co-morbidities will be held at once when the AstraZeneca doses arrive.
Persons with co-morbidities are required to pre-register for the vaccination while master listing of residents who want to avail themselves of the anti-Covid-19 jabs is also ongoing in various barangays in the city.
The rest of the city’s priority A1 groups were vaccinated through a marathon vaccination on March 29 to 31.
Those who received their shots are the remaining members of the barangay health emergency response teams, health workers, students of medical courses who are now deployed to hospitals and health care facilities, such those taking up Medicine, Dentistry and Nursing, Medical Technology; those taking up allied health courses; and faculty members from the College of Nursing whose students will undergo clinical duties.
The rest of the priority groups under Baguio’s vaccination framework are frontline personnel in essential sectors including uniformed personnel (A4), indigent population (A5) teachers and social workers (B1), other government workers (B2), other essential workers (B3), socio-demographic groups at significantly higher risk other than senior citizens and the poor (B4), overseas Filipino workers (B5), other remaining workforce (B6), and rest of the Filipino population (C). – Jane B. Cadalig